© AP Photo/Armando Franca
Surprisingly, it's the New York Times that published an in-depth piece seeking to answer the question: "They Paused Puberty, but Is There a Cost?" The cost not only comes in delayed sexual development but in serious effects such as permanently retarded bone growth, infertility, and potential retarded brain development.
"Many physicians in the United States and elsewhere are prescribing blockers to patients at the first stage of puberty — as early as age 8 — and allowing them to progress to sex hormones as soon as 12 or 13," the Times said (emphasis added). But yet, "the United States had produced no data on the impact or safety of blockers, particularly among transgender patients under 12." There are 300,000 "trans" young Americans between the ages of 13 and 17, the Times reported, and an unknown number younger than that. That's a whole lot of children potentially seeking these treatments. So puberty blockers were being used on kids as young as eight, with no data on the safety and side effects? How is that allowed?
Comment: Back in October when Florida banned 'puberty blockers' and 'sex reassignment surgeries' for minors, Florida Surgeon General Joseph Ladapo had this to say: See also: FDA officials warn of brain swelling, vision loss in minors using puberty blockers